Considerations for Patients with Neurologic Conditions during Pregnancy and Lactation
MotherToBaby supports neurologists in managing neurological diseases during pregnancy and while breastfeeding. We understand the challenges that you face when deciding on treatment courses when your patient is pregnant or breastfeeding. Care of people who are pregnant and lactating with serious conditions like multiple sclerosis (MS), epilepsy, or chronic migraines is further complicated by the physiological changes of pregnancy that may alter symptoms, severity, or treatment needs. Our resources will help you weigh the risks and benefits to both the your patient who is pregnant and their baby as you determine a treatment plan that maximizes disease management and minimizes maternal and fetal/infant risk.
We are also dedicated to furthering the information and understanding of medication safety in pregnancy through our observational MotherToBaby Pregnancy Studies. We are proud to lead more than half of all Food and Drug Administration (FDA)-mandated pregnancy registries conducted in the U.S., including studies on MS treatments. MotherToBaby Pregnancy Studies are rigorously designed cohort studies that aim to provide critically needed product safety information – and your patient referrals make all the difference. With your referral, you are helping us generate data that will lead to improved product safety information in pregnancy, thereby providing you and your MS patients with the evidence you need to make more informed treatment decisions.
Neurological disease in pregnancy is becoming more common as a result of both an increase in neurological diagnoses as well as delayed childbearing. Additionally, medications for neurologic conditions have become increasingly sophisticated in their biological targets; therefore, practitioners must stay up to date in understanding their effects during pregnancy and lactation.— Toscano & Thornburg, 2019
Explore how we can help you and your pregnant and breastfeeding patients by providing no-cost exposure risk assessments, patient education materials, observational studies to monitor pregnancy outcomes, and more.
Related Fact Sheets
- Azathioprine | 6-mercaptopurine
- Bupropion (Wellbutrin®)
- Copolymer 1 (Glatiramer acetate; Glatiramer)
- Dimethyl Fumarate
- Lamotrigine (Lamictal®)
- Multiple Sclerosis
- Ofatumumab (Kesimpta®, Arzerra®)
- Paternal Exposures
- Prednisone | Prednisolone
- Siponimod (Mayzent®)
- Teriflunomide (Aubagio®)
- Topical Corticosteroids
- Topiramate (Topamax®)
- Valproic Acid
We provide no-cost, evidence-based info on exposures during pregnancy or breastfeeding by phone, text, email, and chat.
We offer free patient education materials and provider resources for our information service and pregnancy studies.
Download our LactRx app for on-the-go access to the Library of Medicine’s LactMed database for current information on neurology medications as well as other drugs and vaccinations to which breastfeeding mothers may be exposed.
- National Multiple Sclerosis Society
- Patient Education Genius
- Society for Maternal-Fetal Medicine
- Society for Birth Defects Research & Prevention
- The Mighty
Get answers to the most frequently asked questions about our information service and pregnancy studies.
Stay In Touch
Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.
Refer a Patient
Need to give your patient a personalized assessment on an exposure risk or connect them to our pregnancy studies?